Rebamipide Improves Chronic Inflammation in the Lesser Curvature of the Corpus after Helicobacter pylori Eradication: A Multicenter Study
暂无分享,去创建一个
H. Matsumoto | K. Haruma | J. Hata | N. Manabe | Shinji Tanaka | Kazuhiko Inoue | T. Kamada | Motonori Sato | A. Shiotani | Tetsuo Watanabe | T. Murao | Masanori Ito | T. Akiyama | T. Tokutomi
[1] N. Uedo,et al. Efficacy and safety of 1-week Helicobacter pylori eradication therapy and 7-week rebamipide treatment after endoscopic submucosal dissection of early gastric cancer in comparison with 8-week PPI standard treatment: a randomized, controlled, prospective, multicenter study , 2015, Gastric Cancer.
[2] B. Zhao,et al. Efficacy of Helicobacter pylori Eradication Therapy on Functional Dyspepsia: A Meta-Analysis of Randomized Controlled Studies With 12-Month Follow-up , 2014 .
[3] M. Kudo,et al. Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers. , 2013, World journal of gastroenterology.
[4] O. Kawamura,et al. Development and evaluation of a modified Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease to distinguish functional dyspepsia from non‐erosive reflux disease , 2012, Journal of gastroenterology and hepatology.
[5] M. Hongo,et al. Symptoms and quality of life in underweight gastroesophageal reflux disease patients and therapeutic responses to proton pump inhibitors , 2012, Journal of gastroenterology and hepatology.
[6] Biological agents. Volume 100 B. A review of human carcinogens. , 2012, IARC monographs on the evaluation of carcinogenic risks to humans.
[7] K. Murakami,et al. Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication , 2012, Journal of Gastroenterology.
[8] H. Jung,et al. Healing Effects of Rebamipide and Omeprazole in Helicobacter pylori-Positive Gastric Ulcer Patients after Eradication Therapy: A Randomized Double-Blind, Multinational, Multi-Institutional Comparative Study , 2011, Digestion.
[9] F. Sitas. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (incl Sitas F.) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. A Review of Human Carcinogens , 2011 .
[10] K. Sugano,et al. Guidelines for the Management of Helicobacter pylori Infection in Japan: 2009 Revised Edition , 2010, Helicobacter.
[11] A. Zuckerman,et al. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.
[12] N. Uedo,et al. Predictive Factors for Metachronous Gastric Cancer in High-Risk Patients after Successful Helicobacter pylori Eradication , 2008, Digestion.
[13] M. Asaka,et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial , 2008, The Lancet.
[14] W. Ajiki,et al. Cancer incidence and incidence rates in Japan in 2001 based on the data from 10 population-based cancer registries. , 2007, Japanese journal of clinical oncology.
[15] N. Uedo,et al. Re‐expression of sonic hedgehog and reduction of CDX2 after Helicobacter pylori eradication prior to incomplete intestinal metaplasia , 2007, International journal of cancer.
[16] D. Forman,et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. , 2006, The Cochrane database of systematic reviews.
[17] Susan R. Wilson,et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. , 2011, The Cochrane database of systematic reviews.
[18] K. Chayama,et al. Clinical features of gastric cancer discovered after successful eradication of Helicobacter pylori: results from a 9‐year prospective follow‐up study in Japan , 2005, Alimentary pharmacology & therapeutics.
[19] S. Kluge,et al. Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats , 1993, Digestive Diseases and Sciences.
[20] O. Kawamura,et al. Development and evaluation of FSSG: frequency scale for the symptoms of GERD , 2004, Journal of Gastroenterology.
[21] K. Chayama,et al. Long-Term Rebamipide Therapy Improves Helicobacter pylori-Associated Chronic Gastritis , 2002, Digestive Diseases and Sciences.
[22] D. Forman,et al. An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews , 2003, American Journal of Gastroenterology.
[23] K. Miki,et al. Usefulness of Gastric Cancer Screening Using the Serum Pepsinogen Test Method , 2003, American Journal of Gastroenterology.
[24] K. Chayama,et al. Serum pepsinogen concentration as a marker of Helicobacter pylori infection and the histologic grade of gastritis; evaluation of gastric mucosa by serum pepsinogen levels , 2003, Journal of Gastroenterology.
[25] R. P. Blankfield,et al. Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.
[26] N. Sasaki,et al. Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.
[27] K. Sugano,et al. Guidelines in the Management of Helicobacter pylori Infection in Japan , 2001, Helicobacter.
[28] S. Bhatia,et al. Eradication of Helicobacter pylori in nonulcer dyspepsia. , 2000, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
[29] K. Haruma,et al. Factors That Affect Results of the 13C Urea Breath Test in Japanese Patients , 2000, Helicobacter.
[30] H. Nagai,et al. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. , 1998, Gastroenterology.
[31] K. Haruma,et al. Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects , 1998, American Journal of Gastroenterology.
[32] R. Hunt,et al. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. , 1998, Gastroenterology.
[33] S. Kawasaki,et al. Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. , 1998, Cancer research.
[34] D. Beall. Classification and Grading of Gastritis: The Updated Sydney System , 1997 .
[35] M F Dixon,et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. , 1996, The American journal of surgical pathology.
[36] Y. Naito,et al. Hydroxyl radical scavenging by rebamipide and related compounds: electron paramagnetic resonance study. , 1995, Free radical biology & medicine.
[37] Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. , 1994, IARC monographs on the evaluation of carcinogenic risks to humans.
[38] G. Friedman,et al. Helicobacter pylori infection and the risk of gastric carcinoma. , 1991, The New England journal of medicine.
[39] M. Blaser,et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. , 1991, The New England journal of medicine.
[40] B. Marshall,et al. UNIDENTIFIED CURVED BACILLI ON GASTRIC EPITHELIUM IN ACTIVE CHRONIC GASTRITIS , 1983, The Lancet.